Eve & Co Inc V.EVE.H

Consumer Defensive Household & Personal Products

Eve & Co Incorporated is a Canada-based company, which holds cultivation and processing licenses for the production and sale of various cannabis products, including dried cannabis, cannabis plants and extraction of cannabis oil. It is a licensed producer of medicinal marijuana. It also provides educational information and online support for its customers and first-time buyers. Its products include The Boss Bath Bomb, The Dreamer Bath Bomb, The Lover Bath Bomb, The Optimist CBD Bath Bomb, Indica Blend, Sativa Blend, The Boss, The Confidant, The Creator, The Lover, The Adventurer, The Advocate, and The Free Spirit. Its wholly owned subsidiary is Natural MedCo Ltd. The Boss Bath Bomb has an invigorating blend of sweet orange, lemon, and grapefruit essential oils that come together to enhance and lift mood, reduce stress, and stimulate circulation. The Dreamer Bath Bomb has calming lavender and chamomile essential oils that help to reduce stress and anxiety and promote calmness.

TSXV:EVE.H - Post by User

Eve & Co Inc > More German Market Information

<< Previous

Bullboard Posts

Next >>

Comment by BobbIeheadbobon Sep 02, 2020 2:22pm

97 Views

Post# 31495502

RE:RE:More German Market Information

4 months ? I'm thinking more like 4 days !

Melindababye wrote: She won't.....she doesn't even take calls at investor/shareholder meetings. Eve won't ship to Germany. Eve will be bankrupt in 4 weeks. Greenhouse is 1/3 full. We can't meet German specs to meet first delivery. Employees are disgruntal and fear closure.

mystique1 wrote: when does Melinda loosen up her information pouch?

Aleafia Health to begin medical pot sales in Germany this month
Toronto-based Aleafia Health said Tuesday its German subsidiary has received the necessary permits and licenses to distribute medical cannabis products to pharmacies in the European country. Aleafia expects medical cannabis sales to begin in Germany later this month following approvals from the country's Federal Institute for Drugs and Medical Devices as well as from the local government in Cologne. Aleafia owns 60 per cent of its German subsidiary, with pharmaceutical wholesaler and logistics operator Acnos Pharma holding the remaining ownership stake. The company continues to seek EU-GMP certification for its facility in Paris, Ont., Aleafia said.